kelatorphan has been researched along with atrial natriuretic factor in 2 studies
| Studies (kelatorphan) | Trials (kelatorphan) | Recent Studies (post-2010) (kelatorphan) | Studies (atrial natriuretic factor) | Trials (atrial natriuretic factor) | Recent Studies (post-2010) (atrial natriuretic factor) |
|---|---|---|---|---|---|
| 58 | 0 | 1 | 15,455 | 1,105 | 1,760 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bovy, PR; Krieter, PA; Olins, GM; Spear, KL; Trapani, AJ | 1 |
| Beslot, F; Claperon, N; Fournie-Zaluski, MC; Peyroux, J; Roques, BP | 1 |
2 other study(ies) available for kelatorphan and atrial natriuretic factor
| Article | Year |
|---|---|
Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo.
Topics: Animals; Atrial Natriuretic Factor; Dipeptides; Kidney; Male; Microvilli; Neprilysin; Protease Inhibitors; Rabbits; Rats; Thiorphan | 1989 |
Effect of endopeptidase-24.11 inhibitors and C-ANP receptor ligand on responses evoked in arterioles of rat cremaster muscle by atrial natriuretic peptide.
Topics: Abdominal Muscles; Adenosine; Administration, Topical; Animals; Arterioles; Atrial Natriuretic Factor; Blood Pressure; Dipeptides; Injections, Intravenous; Male; Neprilysin; Nitroprusside; Peptide Fragments; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Thiorphan; Vasodilator Agents | 1995 |